Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.
Quick Facts
What This Study Found
Epidermal keratinocytes produce high levels of interferon-β during skin injury and psoriasis through MAVS signaling activated by the antimicrobial peptide LL37 and double-stranded RNA from necrotic cells. This MAVS-dependent pathway triggers the TBK1-AKT-IRF3 cascade, promoting interferon-β production and dendritic cell maturation.
Key Numbers
How They Did This
The study used human psoriatic and wounded skin samples and mouse models to investigate interferon-β production by keratinocytes. Molecular analyses identified the role of LL37, MAVS, and downstream signaling components in activating interferon-β expression and immune responses.
Why This Research Matters
Understanding how keratinocytes produce interferon-β via LL37 and MAVS reveals key mechanisms driving skin inflammation in diseases like psoriasis and wound healing. This knowledge could guide development of targeted therapies to control harmful skin inflammation.
What This Study Doesn't Tell Us
The study does not specify the exact study type or provide detailed quantitative data on sample sizes, limiting assessment of evidence strength. Further research is needed to confirm findings in larger cohorts and clinical settings.
Trust & Context
- Original Title:
- Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.
- Published In:
- Immunity, 45(1), 119-30 (2016)
- Authors:
- Zhang, Ling-Juan, Sen, George L, Ward, Nicole L, Johnston, Andrew, Chun, Kimberly, Chen, Yifang, Adase, Christopher, Sanford, James A, Gao, Nina, Chensee, Melanie, Sato, Emi, Fritz, Yi, Baliwag, Jaymie, Williams, Michael R, Hata, Tissa, Gallo, Richard L
- Database ID:
- RPEP-03176
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03176APA
Zhang, Ling-Juan; Sen, George L; Ward, Nicole L; Johnston, Andrew; Chun, Kimberly; Chen, Yifang; Adase, Christopher; Sanford, James A; Gao, Nina; Chensee, Melanie; Sato, Emi; Fritz, Yi; Baliwag, Jaymie; Williams, Michael R; Hata, Tissa; Gallo, Richard L. (2016). Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.. Immunity, 45(1), 119-30. https://doi.org/10.1016/j.immuni.2016.06.021
MLA
Zhang, Ling-Juan, et al. "Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.." Immunity, 2016. https://doi.org/10.1016/j.immuni.2016.06.021
RethinkPeptides
RethinkPeptides Research Database. "Antimicrobial Peptide LL37 and MAVS Signaling Drive Interfer..." RPEP-03176. Retrieved from https://rethinkpeptides.com/research/zhang-2016-antimicrobial-peptide-ll37-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.